Elsevier Inc.

SHERPA: Unknown

People

  1. Perales
    Perales
  2. Giralt
    Giralt
  3. Devlin
    Devlin
  4. Shah
    Shah
  5. Park
    Park
  6. Dahi
    Dahi
  7. O'Reilly
    O'Reilly
  8. Palomba
    Palomba
  9. Scordo
    Scordo
  10. Jakubowski
    Jakubowski

Groups

  1. Adult Leukemia (24)
  2. Bone Marrow Transplant (24)
  3. Center for Hematologic Malignancies (24)
  4. Department of Medicine (24)
  5. Hematologic Malignancies, Division of (24)
  6. Survivorship Research (16)
  7. CTCR Scholars (14)
  8. Epidemiology and Biostatistics (13)
  9. Biostatistics Service (12)
  10. GSK Faculty (12)
Search Within
  1. "Miguel-Angel Perales"
  2. "Adult Leukemia"
Formats
  1. Meeting Abstract (16)
  2. Journal Article (6)
  3. Guidelines (2)
Groups
  1. Adult Leukemia (24)
  2. Bone Marrow Transplant (24)
  3. Center for Hematologic Malignancies (24)
  4. Department of Medicine (24)
  5. Hematologic Malignancies, Division of (24)
  6. Survivorship Research (16)

More Groups

People
  1. Miguel-Angel Perales (24)
  2. Sergio Giralt (19)
  3. Sean Devlin (12)
  4. Craig Sauter (11)
  5. Gunjan Shah (10)
  6. Molly Maloy (10)

More People

Years
  1. 2023 (1)
  2. 2022 (5)
  3. 2021 (3)
  4. 2020 (3)
  5. 2019 (4)
  6. 2018 (4)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (15)
  2. Transplantation and Cellular Therapy (7)
  3. International Journal of Radiation Oncology, Biology, Physics (2)

Results (24)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Patterns of relapse and risk reduction following tumor debulking by bridging radiotherapy prior to chimeric antigen receptor T cell therapy in non-Hodgkin lymphoma
    Meeting Abstract

    Hubbeling, H. G.; Silverman, E. A.; Michaud, L.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Alarcon Tomas, A.; Shouval, R.; Palomba, M. L.; Batlevi, C. L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Radiotherapy for relapse after chimeric antigen receptor T cell therapy in hematologic malignancies
    Meeting Abstract

    Hubbeling, H. G.; Silverman, E. A.; Alarcon Tomas, A.; Tringale, K. R.; Wijetunga, N. A.; Hajj, C.; Mailankody, S.; Batlevi, C. L.; Dahi, P. B.; Giralt, S. A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Five-year experience using bridging radiotherapy prior to chimeric antigen receptor (CAR) T-cell therapies for B-cell malignancies
    Meeting Abstract

    Imber, B. S.; Hubbeling, H.; Silverman, E.; Wijetunga, N. A.; Palomba, M. L.; Alarcon Tomas, A.; Shouval, R.; Batlevi, C. W.; Dahi, P. B.; Giralt, S. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in the tyrosine kinase inhibitor era
    Meeting Abstract

    Vaughn, J. L.; Devlin, S. M.; Berman, E.; Mauro, M. J.; Papadopoulos, E. B.; Perales, M. A.; Tallman, M.; Giralt, S. A.; Gyurkocza, B.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Lesion characteristics and patterns of failure in diffuse large B cell lymphoma patients treated with bridging radiotherapy prior to chimeric antigen receptor T cell therapy
    Meeting Abstract

    Hubbeling, H.; Silverman, E.; Wijetunga, N. A.; Palomba, M. L.; Tomas, A. A.; Shouval, R.; Batlevi, C. W.; Dahi, P. B.; Giralt, S. A.; Lin, R. J.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Relapse after allogeneic stem cell transplantation of acute myelogenous leukemia and myelodysplastic syndrome and the importance of second cellular therapy
    Journal Article

    Zuanelli Brambilla, C.; Lobaugh, S. M.; Ruiz, J. D.; Dahi, P. B.; Goldberg, A. D.; Young, J. W.; Gyurkocza, B.; Shaffer, B. C.; Ponce, D. M.; Tamari, R.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Universal engraftment after allogeneic hematopoietic cell transplantation using cryopreserved CD34-selected grafts
    Journal Article

    Jacob, R. P.; Flynn, J.; Devlin, S. M.; Maloy, M.; Giralt, S. A.; Maslak, P.; O'Reilly, R. J.; Tonon, J. A.; Perales, M. A.; Avecilla, S. T.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Hematopoietic cell transplantation in the treatment of newly diagnosed adult acute myeloid leukemia: An evidence-based review from the American Society of Transplantation and Cellular Therapy
    Guidelines

    Dholaria, B.; Savani, B. N.; Hamilton, B. K.; Oran, B.; Liu, H. D.; Tallman, M. S.; Ciurea, S. O.; Holtzman, N. G.; Phillips, G. L. 2nd; Devine, S. M.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Durable remission following "off-the-shelf" chimeric antigen receptor (CAR) T-cells in patients with relapse/refractory (R/R) B-cell malignancies
    Meeting Abstract

    Curran, K. J.; Sauter, C. S.; Kernan, N. A.; Prockop, S. E.; Boulad, F.; Perales, M.; Giralt, S. A.; Riviere, I.; Wang, X.; Boelens, J. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save